Replies to post #184521 on Biotech Values

[DewDiligence]

Xoma is not a "well established company"…

Exactly the point—I would’ve thought XOMA was well enough established to be able to finance without warrants.

…and neither are most research-stage biotechs.

Yet the overwhelming majority of recent financings by such companies have been warrant-free.